Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Sichuan Kangle Pharmaceutical is a specialized pharmaceutical manufacturer based in Chengdu, China, and a subsidiary of the state-owned China National Pharmaceutical Group (Sinopharm). The company is a major producer of antibiotics, particularly lincosamides, and provides a range of active pharmaceutical ingredients (APIs) and finished dosage forms. Its manufacturing facilities are GMP-certified, supporting the production of high-quality generic medications for both domestic and global markets. By leveraging Sinopharm's research and distribution infrastructure, the company plays a vital role in the supply of essential anti-infective therapies. Its portfolio includes widely used treatments such as clindamycin and lincomycin, catering to various clinical needs in infectious disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China National Pharmaceutical Group Sichuan Kangle Pharmaceutical.